Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.